Screening for HIV Among Patients at Tuberculosis Clinics — Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015–2016

The World Health Organization and national guidelines recommend HIV testing and counseling at tuberculosis (TB) clinics for all patients, regardless of TB diagnosis (1). Population-based HIV Impact Assessment (PHIA) survey data for 2015-2016 in Malawi, Zambia, and Zimbabwe were analyzed to assess HIV screening at TB clinics among persons who had positive HIV test results in the survey. The analysis was stratified by history of TB diagnosis* (presumptive versus confirmed†), awareness§ of HIV-positive status, antiretroviral therapy (ART)¶ status, and viral load suppression among HIV-positive adults, by history of TB clinic visit. The percentage of adults who reported having ever visited a TB clinic ranged from 4.7% to 9.7%. Among all TB clinic attendees, the percentage who reported that they had received HIV testing during a TB clinic visit ranged from 48.0% to 62.1% across the three countries. Among adults who received a positive HIV test result during PHIA and who did not receive a test for HIV at a previous TB clinic visit, 29.4% (Malawi), 21.9% (Zambia), and 16.2% (Zimbabwe) reported that they did not know their HIV status at the time of the TB clinic visit. These findings represent missed opportunities for HIV screening and linkage to HIV care. In all three countries, viral load suppression rates were significantly higher among those who reported ever visiting a TB clinic than among those who had not (p<0.001). National programs could strengthen HIV screening at TB clinics and leverage them as entry points into the HIV diagnosis and treatment cascade (i.e., testing, initiation of treatment, and viral load suppression).

[1]  Catherine Ngugi,et al.  Community Mobilization Approaches for Large-Scale Public Health Surveys: Experiences from the Population-based HIV Impact Assessment (PHIA) Project , 2022, Journal of Community Health.

[2]  M. Muyoyeta,et al.  Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study , 2018, BMC Infectious Diseases.

[3]  S. Pals,et al.  Increasing partner HIV testing and linkage to care in TB settings: findings from an implementation study in Pwani, Tanzania , 2018, AIDS care.

[4]  R. Sahabo,et al.  Status of HIV Epidemic Control Among Adolescent Girls and Young Women Aged 15–24 Years — Seven African Countries, 2015–2017 , 2018, MMWR. Morbidity and mortality weekly report.

[5]  M. Yotebieng,et al.  Provider-Initiated HIV testing and counseling among patients with presumptive tuberculosis in Democratic Republic of Congo , 2016, The Pan African Medical Journal.

[6]  K. D. de Cock,et al.  Tuberculosis and HIV at the National Level in Kenya: Results From the Second Kenya AIDS Indicator Survey , 2014, Journal of acquired immune deficiency syndromes.

[7]  F. Varaine,et al.  Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  N. Jarrett,et al.  Patient and provider perspectives on implementation models of HIV counseling and testing for patients with TB. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9]  K. D. de Cock,et al.  Provider-initiated HIV testing and counselling for TB patients and suspects in Nairobi, Kenya. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  K. D. de Cock,et al.  Provider-initiated HIV testing and counselling for TB patients and suspects in Nairobi, Kenya. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.